Dr.Brill + Prof. Bockmühl News Center

November 29, 2022
Are you interested in wound healing? We are as well!
And in order to be a good partner to you in the usual competent manner with regard to this issue, we develop tests for you and with you on the subject of antimicrobial wound treatment products. Since this sector still has some catching up to do in terms of international standards, but we already see a need for action today, we are active on various issues. In particular, the establishment of the concept of biofilms in the context of wound treatment is of great interest, because its special properties must first be understood and taken into account in the treatment. Therefore, we conduct research with our collaboration partners (e.g.: Prof. Dr. med. Ewa Stürmer, UKE; PD Dr. Cornelia Wiegand, Jena University Hospital; Dr. med. Thomas Eberlein, Woundconsulting) on various topics and share our findings on an expert stage: Influence on decolonization and biofilm reduction of urinary tract catheters by rinsing with polyhexanide (DOI: 10.1186/s12894-018-0362-3 and 10.1186/s12894-021-00826-3) Antimicrobial wound dressings in their effectiveness against Pseudomonas aeruginosa biofilms (DOI: 10.3389/fmicb.2021.664030) Alternative treatment of biofilms by stimulating wound healing using “Pulsed low-intensity laser treatment” (DOI: 10.1016/j.jphotobiol.2022.112504) Development of a new 3D skin infection model as an alternative to animal models as part of the "InVitroWund" cooperation project (DGKH Congress 2022, CAHMV Congress 2021)   What we can do for you: Do you have an interesting project on the subject and do you need advisory support? Due to our strong commitment at standardization level and our broad network, we can offer you our help even before the experimental work. Do you already have a question that you would like to support experimentally? Then please contact us. This can be in the context of biofilms but also generally on the subject of wound dressings. We not only offer you the standard tests that you need for your approval (e.g.: suspension tests according to EN 13727 and EN 13624). We also plan and carry out projects based on our established in-house methods in order to achieve standardization today, even without an internationally valid standard. Is your project planning possibly still in the future? Then we are pleased to inform you that prEN17854:2022-07 has currently reached draft status, so that we may soon be able to offer you an internationally valid test standard. Do you have a request that is not listed here? No problem, please contact our team at   Current: Since the topic always provides an opportunity for exchange, we cordially invite you to the event "Online Update Hygiene and Infection Prevention" of the Life Science Nord network on December 8th, 2022 (, which among other things focuses on wound treatment and which you can also view after uploading on-demand in the media center ( We look forward to exchanging ideas with you!
November 2, 2022
Your study according to GLP? No problem!
Do you need GLP-compliant testing for your biocide registration or your medical device? Then please feel free to contact us. Dr. Brill + Partner has been certified as a GLP testing facility since June 2020 and registered with the BfR as a testing facility with the corresponding test category since July 2021. This certification includes: Tests for the determination of toxicological properties (category 2) Tests for the determination of mutagenic properties (in vitro, in vivo) (category 3) Microbiological and biochemical testing of cleaning, disinfection and sterilization processes) (category 9) You don't know whether you should have a GLP test performed for your products? Please feel free to contact us! We will advise you comprehensively regarding the requirements for different legal areas (EU, USA/FDA), the demarcation to GMP and GCP and the possible laboratory tests. What we can do for you: Specifically, we have the following standards for you under GLP, which you are welcome to request at ASTM E2755 (Bacteria-Eliminating Effectiveness of Healthcare Personnel Hand Rub) AOAC 955.17 (Fungicidal Activity of Disinfectants) EN 13697 (bactericidal and/or fungicidal activity of chemical disinfectants on non-porous surfaces without mechanics) DIN EN ISO 10993-5 (tests for in vitro cytotoxicity of medical devices) Is your standard/test standard not listed? Please contact us anyway, because we have further methods in the GLP pipeline.
October 30, 2022
eSignature for test reports, statements and expert opinions
Dear customer, we are pleased to inform you that as of 01.01.2023 we will modernize our document dispatch by switching to documents with eSignature. The eSignature we use meets the requirements for an advanced eSignature in accordance with EU Regulation 910/2014 and thus enables us to make our processes more secure, modern and flexible in your interests. The implementation will take place gradually, so it is possible that especially for your request everything will still be handled as you are used to. For the processes that have already been implemented, this means that from this point on you will only be provided with an electronically signed document in the form of a PDF. The previously standard dispatch of hardcopy copies with wet signatures will therefore no longer be necessary. Of course, we offer you the usual service and thus the possibility, for an additional charge, to receive a hardcopy copy in addition to the document with eSignature. The new process: As a better orientation for you, from 01.01.2023 on newly issued quotations and order confirmations, an information about this change will be embedded in the document dispatch. We therefore ask you to inform us ideally already when preparing the quotation, but at the latest when placing the order, whether you would like a hardcopy copy, so that we can take this request into account in the order confirmation and internal processes. If you only request a hardcopy copy after the order has been placed, this request will of course also be taken into account by providing a separate quotation for the additional costs. If your request from 01.01.2023 is not yet affected by the implementation, we will of course refrain from additional costs despite the information on the quotation and order confirmation. Transition period: For all implemented processes, the following applies: all orders received before the implementation deadline will be completed as usual with a hardcopy copy, which in this case is of course free of charge for you. In addition, however, you will then already receive the PDF with eSignature. The new process will only be applied in its entirety for new inquiries/orders. The following applies to all processes that have not yet been implemented: We are, of course, striving to create a uniform system for you. We therefore plan to have implemented all processes to the eSignature by 01.07.2023